Related Experiment Video

Updated: Aug 21, 2026

The Soft Agar Colony Formation Assay
08:01

The Soft Agar Colony Formation Assay

Published on: October 27, 2014

Wnt/beta-catenin-pathway as a molecular target for future anti-cancer therapeutics

Susanne Dihlmann1, Magnus von Knebel Doeberitz

  • 1Institute of Molecular Pathology, University of Heidelberg, Im Neuenheimer Feld 220/221, D-69120 Heidelberg, Germany. susanne.dihlmann@med.uni-heidelberg.de

International Journal of Cancer
|October 9, 2004
PubMed

Insights

Targeting the Wnt/beta-catenin pathway offers new hope for cancer treatment. Disrupting this pathway, crucial in colorectal cancer, can lead to novel therapeutic strategies and improved patient outcomes.

Area of Science:

  • Oncology
  • Molecular Biology
  • Drug Discovery

Background:

  • Conventional chemotherapy offers limited benefits for advanced cancer patients.
  • Hyperactivity of the Wnt/beta-catenin signaling pathway drives colorectal and other cancers.
  • This pathway leads to constitutive gene transactivation, promoting tumor growth.

Purpose of the Study:

  • To review therapeutic strategies targeting the Wnt/beta-catenin pathway.
  • To identify novel agents for improved cancer treatment outcomes.
  • To explore methods for blocking uncontrolled pathway activation.

Main Methods:

  • Review of recent therapeutic strategies.
  • Focus on agents disrupting the Wnt/beta-catenin pathway.
  • Identification of potential lead compounds for anticancer therapeutics.

Main Results:

  • Several therapeutic strategies can interfere with tumor growth by blocking Wnt/beta-catenin activation.
  • Potential therapeutic agents include repurposed drugs, biomolecules, and targeted small molecules.
  • Disruption of protein-protein interactions within the pathway is a promising approach.

Conclusions:

  • Targeting the Wnt/beta-catenin pathway is a promising strategy for novel cancer therapeutics.
  • Diverse approaches, including small molecules and biologics, show potential.
  • Further development of these antagonists could lead to improved cancer treatments.

More Related Videos

Reconstitution Of β-catenin Degradation In Xenopus Egg Extract09:41

Reconstitution Of β-catenin Degradation In Xenopus Egg Extract

Published on: June 17, 2014

Related Concept Videos

Canonical Wnt Signaling Pathway02:54

Canonical Wnt Signaling Pathway

The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which results in tumor...
Non-Canonical Wnt Signaling Pathways01:41

Non-Canonical Wnt Signaling Pathways

Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Catenins01:23

Catenins

Catenins are characterized by multiple binding domains and dynamic structures that allow them to function as linker proteins in cell junction complexes. All catenins, except α-catenin, contain a characteristic protein sequence called the armadillo repeat and are therefore also called armadillo proteins.
Catenins in Cell Junctions
Catenins bind to cell adhesion molecules such as cadherins and link them to different cytoskeletal proteins depending on the type of cell junction. At the adherens...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...